Hangzhou Tigermed Consulting Co., Ltd
Status: Publicly traded
Direct answer
Hangzhou Tigermed Consulting Co., Ltd is publicly traded on HKSE under the ticker 3347.HK.
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is...
Can you invest in Hangzhou Tigermed Consulting Co., Ltd?
Yes. Hangzhou Tigermed Consulting Co., Ltd is publicly traded on HKSE under the ticker 3347.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hangzhou Tigermed Consulting Co., Ltd
Detailed equity research is provided by MarketSnap.